TradingView
warrenhochfeld
Nov 2, 2017 8:44 PM
Dynavax breakout ahead of Heplisav approval
Long
NASDAQ:DVAX
60
Dynavax Technologies Corporation
NASDAQ
Description
⋅
Nov 2, 2017 8:44 PM
Start of final bull run ahead of 9th November FDA announcement of Heplisav approval
$25-$30 price projection
Trend Analysis
Beyond Technical Analysis
biotech
More